Capricor Therapeutics reported $-4315000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Bluebird Bio BLUE:US $ -216.95M 23.88M
Capricor Therapeutics CAPR:US $ -4.32M 0.45M
Cytokinetics CYTK:US $ -69.2M 14.4M
Cytori Therapeutics CYTX:US $ -3499000 924K
Geron GERN:US $ -25.67M 3.22M
Johnson & Johnson JNJ:US $ 3849M 2813M
Newlink Genetics NLNK:US -7497000 1.17M
Prothena PRTA:US 109.23M 81.28M
Ptc Therapeutics PTCT:US $ -93.08M 5.42M
Sarepta Therapeutics SRPT:US $ -38.95M 128.63M
Vascular Biogenics VBLT:US -6513000 1.51M